
Sure Med Compliance
On a mission to create safer exposures to control substances through facilitating greater prescribing compliance.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
* | $250k | Grant | |
Total Funding | 000k |
USD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Established in 2016, Sure Med Compliance operates within the digital health sector, focusing on enhancing safety and compliance in the prescription of controlled substances. The Mobile, Alabama-based company was founded by John Bowman, who now serves as CEO. Bowman, a veteran of the United States Coast Guard and a graduate of the University of South Florida, brings nearly two decades of healthcare industry experience, particularly in marketing, sales, and addressing medicolegal risk in pain management. His background in co-founding other healthcare startups has shaped the company's approach to mitigating risks for both physicians and patients in pain management settings.
The company's core offering is the 'Perspectives in Care' platform, a digital tool designed to address the complexities of prescribing controlled substances. This platform functions as an electronic patient-reported outcome (ePRO) system that gathers data from patients, which is then scored, summarized, and delivered to the healthcare provider's electronic health record. This process provides clear documentation to support the medical necessity of a prescription, thereby reducing liability for providers and enhancing safety for patients. The platform is scientifically validated to mitigate risk for both parties involved in pain management. Sure Med Compliance serves healthcare providers, specifically those in pain management, and plans to expand into orthopedics, acute care, and addiction medicine. The business model has a dual revenue stream. While the platform is offered as a sponsored resource for healthcare providers, it also features a private marketplace. This marketplace allows life sciences companies to deliver highly targeted advertisements to healthcare professionals at the point of care.
Significant milestones for Sure Med Compliance include receiving a Direct-to-Phase 2 SBIR grant from the National Institutes of Health in 2020, which led to a clinical trial in partnership with the University of Florida's College of Pharmacy. In October 2022, the company secured $1 million in a pre-Series A funding round. The round was led by ProAssurance, a major medical malpractice insurance provider, and included a $250,000 grant from Innovate Alabama. This capital was aimed at funding the national launch of the 'Perspectives in Care' platform and developing new platforms for adjacent markets. Keywords: controlled substance compliance, prescribing software, digital health, pain management technology, medicolegal risk mitigation, ePRO, electronic patient-reported outcomes, clinical decision support, healthcare advertising, prescription drug safety, opioid prescribing, physician liability, patient safety, health data analytics, ProAssurance, John Bowman, Perspectives in Care, Innovate Alabama, healthcare risk management, medical malpractice